Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.76 USD
Change Today 0.00 / 0.00%
Volume 112.9K
MBLX On Other Exchanges
Symbol
Exchange
MBLX is not on other exchanges.
As of 8:10 PM 04/24/15 All times are local (Market data is delayed by at least 15 minutes).

metabolix inc (MBLX) Snapshot

Open
$0.74
Previous Close
$0.76
Day High
$0.79
Day Low
$0.74
52 Week High
09/8/14 - $1.51
52 Week Low
12/10/14 - $0.25
Market Cap
102.9M
Average Volume 10 Days
77.8K
EPS TTM
$-0.61
Shares Outstanding
135.4M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for METABOLIX INC (MBLX)

Related News

No related news articles were found.

metabolix inc (MBLX) Related Businessweek News

No Related Businessweek News Found

metabolix inc (MBLX) Details

Metabolix, Inc., an advanced biomaterials company, focuses on delivering sustainable solutions to the plastics industry. The company develops and commercializes technologies for the production of polymers and chemicals in microbes and plants. It produces a family of biopolymers found in nature called polyhydroxyalkanoates (PHA), which occur naturally in living organisms and are chemically similar to polyesters. The company offers biobased polymeric modifiers for rigid, semi-rigid, and flexible polyvinyl chloride compounds, which are used in construction materials and medical applications. It is also developing PHA biopolymers as performance additives, and biobased and marine biodegradable micropowders for functional biodegradation; and PHA barrier coatings for use in paper and cardboard applications. In addition, the company has entered into a commercial and technology alliance with Honeywell International, Inc. for the development of marine biodegradable biopolymers for use in cosmetics and personal care products. The company offers its biopolymers under the Mirel brand. Metabolix, Inc. was founded in 1992 and is based in Cambridge, Massachusetts.

68 Employees
Last Reported Date: 03/25/15
Founded in 1992

metabolix inc (MBLX) Top Compensated Officers

Co-Founder, Chief Scientific Officer and Dire...
Total Annual Compensation: $240.0K
Chief Operating Officer
Total Annual Compensation: $278.3K
Vice President of Marketing and Corporate Com...
Total Annual Compensation: $220.0K
Compensation as of Fiscal Year 2013.

metabolix inc (MBLX) Key Developments

Metabolix, Inc. Auditor Raises 'Going Concern' Doubt

Metabolix, Inc. filed its 10-K on Mar 25, 2015 for the period ending Dec 31, 2014. In this report its auditor, PricewaterhouseCoopers LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.

Metabolix, Inc. Announces Unaudited Consolidated Earnings Results for the Fourth Quarter and Year Ended December 31, 2014; Provides Financial Guidance for 2015

Metabolix, Inc. announced unaudited consolidated earnings results for the fourth quarter and year ended December 31, 2014. For the quarter, the company reported total revenue of $856,000 compared to $746,000 a year ago. Loss from continuing operations was $5,852,000 compared to $7,959,000 a year ago. Net loss from continuing operations was $5,807,000 or $0.05 per basic and diluted share compared to $7,967,000 or $0.23 per basic and diluted share a year ago. Net loss was $6,252,000 or $0.05 per basic and diluted share compared to $8,627,000 or $0.25 per basic and diluted share a year ago. For the year, the company reported total revenue of $2,800,000 compared to $3,778,000 a year ago. Loss from continuing operations was $26,829,000 compared to $28,540,000 a year ago. Net loss from continuing operations was $26,768,000 or $0.44 per basic and diluted share compared to $28,544,000 or $0.83 per basic and diluted share a year ago. Net loss was $29,534,000 or $0.48 per basic and diluted share compared to $30,506,000 or $0.88 per basic and diluted share a year ago. Net cash used in operating activities was $24,244,000 compared to $26,648,000 a year ago. Purchase of property and equipment was $172,000 compared to $373,000 a year ago. Cash usage in 2015 should be slightly lower than 2014 due to headcount reduction last year largely offset by increased cash costs associated with expanded biopolymer production this year. Based on current plans, The company anticipates cash usage of approximately $23 million in 2015. This includes $1 million of capital expenditures for pilot capacity. The expansion of pilot recovery operation will require a small capital investment estimated at approximately $1 million. This capital is being used to purchase equipment and install it within the existing footprint of the recovery facility.

Metabolix, Inc. to Report Q4, 2014 Results on Mar 19, 2015

Metabolix, Inc. announced that they will report Q4, 2014 results at 4:30 PM, US Eastern Standard Time on Mar 19, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MBLX:US $0.76 USD 0.00

MBLX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for MBLX.
View Industry Companies
 

Industry Analysis

MBLX

Industry Average

Valuation MBLX Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 32.3x
Price/Book 5.5x
Price/Cash Flow NM Not Meaningful
TEV/Sales 29.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact METABOLIX INC, please visit www.metabolix.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.